Biocon Gets US Regulator Nod For Biosimilar Of Cancer Drug, Shares Up 14%
Business
Following the announcement, shares of the company opened on a bullish note and surged 14.20 per cent to touch an early high of Rs 510 on the Bombay St...
Comments